ASCO GU 2022: Phase II Trial Suggests Immunotherapy May Play Role in Management of Advanced Penile Cancer
Biomarkers are needed to determine who is a likely responder
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.